| Literature DB >> 30897229 |
Kazumi Urata1, Ikko Kajihara1, Tselmeg Mijiddorj Myangat1, Yukino Tasaki1, Saki Otsuka-Maeda1, Soichiro Sawamura1, Saori Kanazawa-Yamada1, Ryoko Sakamoto1, Katsunari Makino1, Jun Aoi1, Toshikatsu Igata1, Takamitsu Makino1, Shinichi Masuguchi1, Satoshi Fukushima1, Masatoshi Jinnin1, Hironobu Ihn1.
Abstract
Cyclin-dependent kinase 4 and 6 (CDK4/6) plays an important role in cell cycle progression, and the CDK4/6-cyclin D1 complex controls the cell cycle transition from G1 phase to S phase. CDK4 is enhanced in several types of cancers and CDK4/6 inhibitors attenuate the proliferation of several types of cancer in vitro/in vivo. The purpose of our study was to investigate the expression pattern of CDK4 and evaluate its clinical importance in extramammary Paget's disease (EMPD). Almost all EMPD tissues were positive for CDK4, and metastatic lesions had a similar immunostaining intensity to primary lesions. In addition, CDK4 protein levels were positively correlated with those of cyclin D1 protein. Taken together, CDK4 may assume a crucial role in EMPD progression.Entities:
Keywords: CDK4; cyclin D1; immunohistochemistry; metastasis; therapeutic target
Mesh:
Substances:
Year: 2019 PMID: 30897229 DOI: 10.1111/1346-8138.14858
Source DB: PubMed Journal: J Dermatol ISSN: 0385-2407 Impact factor: 4.005